Adeno-Associated Virus (AAV) Versus Immune Response
Decades ago, Friedmann and Roblin postulated several barriers to gene therapy, including tissue targeting, delivery across the blood⁻brain barrier (BBB), and host immune responses. These issues remain pertinent till today. Since then, several advances have been made in elucidating structur...
Main Authors: | Joseph Rabinowitz, Ying Kai Chan, Richard Jude Samulski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/2/102 |
Similar Items
-
Monobac System–A Single Baculovirus for the Production of rAAV
by: Lionel Galibert, et al.
Published: (2021-08-01) -
Evaluation of gene transfer strategies using recombinant adeno-associated viruses for Parkinson’s disease cell and gene therapy/Evaluation de stratégies de transfert de gènes via les virus adéno-associés recombinants pour la thérapie génique et cellulaire de la maladie de Parkinson
by: Bockstael, Olivier
Published: (2010) -
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020-08-01) -
Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01) -
Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia
by: Marie Reine Haddad, et al.
Published: (2013-01-01)